These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 29752026)

  • 21. The integrated phase III safety profile of the pentavalent human-bovine (WC3) reassortant rotavirus vaccine.
    Dennehy PH; Goveia MG; Dallas MJ; Heaton PM
    Int J Infect Dis; 2007 Nov; 11 Suppl 2():S36-42. PubMed ID: 18162245
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative evaluation of safety and immunogenicity of two dosages of an oral live attenuated human rotavirus vaccine.
    Dennehy PH; Brady RC; Halperin SA; Ward RL; Alvey JC; Fischer FH; Innis BL; Rathfon H; Schuind A; De Vos B;
    Pediatr Infect Dis J; 2005 Jun; 24(6):481-8. PubMed ID: 15933555
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human Neonatal Rotavirus Vaccine (RV3-BB) to Target Rotavirus from Birth.
    Bines JE; At Thobari J; Satria CD; Handley A; Watts E; Cowley D; Nirwati H; Ackland J; Standish J; Justice F; Byars G; Lee KJ; Barnes GL; Bachtiar NS; Viska Icanervilia A; Boniface K; Bogdanovic-Sakran N; Pavlic D; Bishop RF; Kirkwood CD; Buttery JP; Soenarto Y
    N Engl J Med; 2018 Feb; 378(8):719-730. PubMed ID: 29466164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase I trial of RV3-BB rotavirus vaccine: a human neonatal rotavirus vaccine.
    Danchin M; Kirkwood CD; Lee KJ; Bishop RF; Watts E; Justice FA; Clifford V; Cowley D; Buttery JP; Bines JE
    Vaccine; 2013 May; 31(23):2610-6. PubMed ID: 23597719
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and immunogenicity of RV3-BB human neonatal rotavirus vaccine administered at birth or in infancy: a randomised, double-blind, placebo-controlled trial.
    Bines JE; Danchin M; Jackson P; Handley A; Watts E; Lee KJ; West A; Cowley D; Chen MY; Barnes GL; Justice F; Buttery JP; Carlin JB; Bishop RF; Taylor B; Kirkwood CD;
    Lancet Infect Dis; 2015 Dec; 15(12):1389-97. PubMed ID: 26318715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methodology and lessons-learned from the efficacy clinical trial of the pentavalent rotavirus vaccine in Bangladesh.
    Zaman K; Yunus M; El Arifeen S; Azim T; Faruque AS; Huq E; Hossain I; Luby SP; Victor JC; Dallas MJ; Lewis KD; Rivers SB; Steele AD; Neuzil KM; Ciarlet M; Sack DA
    Vaccine; 2012 Apr; 30 Suppl 1():A94-100. PubMed ID: 22520143
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The human rotavirus vaccine RIX4414 in infants: a review of safety and tolerability.
    Cheuvart B; Friedland LR; Abu-Elyazeed R; Han HH; Guerra Y; Verstraeten T
    Pediatr Infect Dis J; 2009 Mar; 28(3):225-32. PubMed ID: 19209095
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rotavirus vaccine (RotaTeq).
    Keating GM
    Paediatr Drugs; 2006; 8(3):197-202; discussion 203-4. PubMed ID: 16774301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An analysis of rotavirus vaccine reports to the vaccine adverse event reporting system: more than intussusception alone?
    Haber P; Chen RT; Zanardi LR; Mootrey GT; English R; Braun MM;
    Pediatrics; 2004 Apr; 113(4):e353-9. PubMed ID: 15060267
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dose response and efficacy of a live, attenuated human rotavirus vaccine in Mexican infants.
    Ruiz-Palacios GM; Guerrero ML; Bautista-Márquez A; Ortega-Gallegos H; Tuz-Dzib F; Reyes-González L; Rosales-Pedraza G; Martínez-López J; Castañón-Acosta E; Cervantes Y; Costa-Clemens S; DeVos B
    Pediatrics; 2007 Aug; 120(2):e253-61. PubMed ID: 17606534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and tolerability of a liquid bovine rotavirus pentavalent vaccine (LBRV-PV) in adults.
    Anil K; Desai S; Bhamare C; Dharmadhikari A; Madhusudhan RL; Patel J; Kulkarni PS
    Vaccine; 2018 Mar; 36(12):1542-1544. PubMed ID: 29439867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Active surveillance for intussusception in a phase III efficacy trial of an oral monovalent rotavirus vaccine in India.
    John J; Kawade A; Rongsen-Chandola T; Bavdekar A; Bhandari N; Taneja S; Antony K; Bhatnagar V; Gupta A; Kabra M; Kang G
    Vaccine; 2014 Aug; 32 Suppl 1():A104-9. PubMed ID: 25091662
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Malnutrition levels among vaccinated and unvaccinated children between 2 and 3 years of age following enrollment in a randomized clinical trial with the pentavalent rotavirus vaccine (PRV) in Bangladesh.
    Feller AJ; Zaman K; Lewis KD; Hossain I; Yunus M; Sack DA
    Vaccine; 2012 Apr; 30 Suppl 1():A101-5. PubMed ID: 22520118
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of pentavalent rotavirus vaccine in a high HIV prevalence population in Kenya.
    Feikin DR; Laserson KF; Ojwando J; Nyambane G; Ssempijja V; Audi A; Nyakundi D; Oyieko J; Dallas MJ; Ciarlet M; Neuzil KM; Breiman RF
    Vaccine; 2012 Apr; 30 Suppl 1():A52-60. PubMed ID: 22520137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of a live oral human rotavirus vaccine after programmatic introduction in Bangladesh: A cluster-randomized trial.
    Zaman K; Sack DA; Neuzil KM; Yunus M; Moulton LH; Sugimoto JD; Fleming JA; Hossain I; Arifeen SE; Azim T; Rahman M; Lewis KDC; Feller AJ; Qadri F; Halloran ME; Cravioto A; Victor JC
    PLoS Med; 2017 Apr; 14(4):e1002282. PubMed ID: 28419095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian infants: a randomised, double-blind, placebo-controlled trial.
    Bhandari N; Rongsen-Chandola T; Bavdekar A; John J; Antony K; Taneja S; Goyal N; Kawade A; Kang G; Rathore SS; Juvekar S; Muliyil J; Arya A; Shaikh H; Abraham V; Vrati S; Proschan M; Kohberger R; Thiry G; Glass R; Greenberg HB; Curlin G; Mohan K; Harshavardhan GV; Prasad S; Rao TS; Boslego J; Bhan MK;
    Lancet; 2014 Jun; 383(9935):2136-43. PubMed ID: 24629994
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spotlight on pentavalent rotavirus vaccine (RotaTeq) in the prevention of rotavirus gastroenteritis in Europe.
    Plosker GL
    BioDrugs; 2010 Dec; 24(6):411-4. PubMed ID: 21043548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and immunogenicity of two or three dose rotavirus-vaccine regimen in South African children over two consecutive rotavirus-seasons: a randomized, double-blind, placebo-controlled trial.
    Madhi SA; Kirsten M; Louw C; Bos P; Aspinall S; Bouckenooghe A; Neuzil KM; Steele AD
    Vaccine; 2012 Apr; 30 Suppl 1():A44-51. PubMed ID: 22520136
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunogenicity of an oral rotavirus vaccine administered with prenatal nutritional support in Niger: A cluster randomized clinical trial.
    Isanaka S; Garba S; Plikaytis B; Malone McNeal M; Guindo O; Langendorf C; Adehossi E; Ciglenecki I; Grais RF
    PLoS Med; 2021 Aug; 18(8):e1003720. PubMed ID: 34375336
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of rhesus rotavirus monovalent and tetravalent reassortant vaccines in US children. US Rotavirus Vaccine Efficacy Group.
    Bernstein DI; Glass RI; Rodgers G; Davidson BL; Sack DA
    JAMA; 1995 Apr; 273(15):1191-6. PubMed ID: 7707626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.